Getz Pharma’s Astola Facility achieves WHO Prequalification, reinforcing global quality leadership
Getz Pharma has received World Health Organization (WHO) Prequalification for its Astola manufacturing facility, one of the largest pharmaceutical manufacturing facilities in South Asia, on 2 November 2026. This achievement demonstrates that the facility meets internationally recognized standards of quality, safety, and efficacy, further reinforcing Getz Pharma’s commitment to delivering high-quality medicines to patients worldwide.
WHO Prequalification is among the most stringent quality benchmarks in the global pharmaceutical industry. The assessment involves a comprehensive evaluation of manufacturing facilities, products, processes, and quality management systems against globally recognised standards. WHO Prequalification enables eligible medicines to be considered for procurement by United Nations agencies and other global health organisations, supporting broader access to quality-assured medicines worldwide.
In 2013, Getz Pharma’s Quality Control (QC) laboratories became the first in the region to achieve WHO Prequalification. This was followed by PIC/S approval in 2014 and WHO Prequalification of a Getz Pharma manufacturing facility in 2017. The Astola facility now joins this legacy of internationally recognised certifications, prequalification, and regulatory........
